Literature DB >> 3690985

Social and emotional problems in early rheumatoid arthritis. 75 patients followed up for two years.

H H Raspe1.   

Abstract

Seventy-five patients with an early RA (disease duration between 2 and 12 months; 79% female; average age 49 years; 72% with "definite" RA) were followed in a prospective study over a period of 2 years. Within this 24 month observation period there was a drop in the average diagnostic ARA count from 5.0 to 4.2, in the ESR from 48 to 31 mm within the first hour and also in the number of affected joints from 13 to 9. Pain intensity and functional capacity showed a slight decrease in the average score. Despite a consistent antirheumatic therapy (72% on RID's after one year) there was a noticeable increase from 23 to 58% in the prevalence of patients with any erosive changes in the X-ray. Within the two years of this study one third of the patients employed at the onset had to quit their job. The number of patients retired due to RA rose from 0 to 23%. A comparison of two groups of patients (employed versus retired) revealed no significant differences in the initial examination with one exception: The patients eventually retired by the end of the study were significantly older with an average age of 51 versus 39 in the group of still employed patients. On the other hand, by the end of the study the patients remaining employed for the duration of the 2 years were significantly less active and also less severely diseased and handicapped. The number of patients with clinically relevant depression (BDI) or anxiety (STAI) did not change significantly over the 24 month period.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3690985     DOI: 10.1007/bf02203381

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  1958 REVISION of diagnostic criteria for rheumatoid arthritis.

Authors: 
Journal:  Arthritis Rheum       Date:  1959-02

3.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

4.  [Does seronegative chronic polyarthritis have a special place? Clinical, biochemical and immunogenetic profile of early seronegative seropositive chronic polyarthritis].

Authors:  H H Raspe; A Vorbeck; M Robin-Winn
Journal:  Dtsch Med Wochenschr       Date:  1986-09-26       Impact factor: 0.628

5.  A controlled home interview study of factors associated with early rheumatoid arthritis.

Authors:  D L Jacob; H Robinson; A T Masai
Journal:  Am J Public Health       Date:  1972-11       Impact factor: 9.308

6.  Work disability in rheumatoid arthritis: effects of disease, social, and work factors.

Authors:  E Yelin; R Meenan; M Nevitt; W Epstein
Journal:  Ann Intern Med       Date:  1980-10       Impact factor: 25.391

7.  Aspects of the psychology and epidemiology of rheumatoid disease.

Authors:  S Crown; J M Crown; A Fleming
Journal:  Psychol Med       Date:  1975-08       Impact factor: 7.723

8.  Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors:  R S Pinals; A T Masi; R A Larsen
Journal:  Arthritis Rheum       Date:  1981-10
  8 in total
  3 in total

1.  [Clinical diagnosis and documentation of chronic-rheumatic pain syndromes the state of the art 1990.].

Authors:  H H Raspe; T Kohlmann
Journal:  Schmerz       Date:  1991-03       Impact factor: 1.107

2.  Self report functional disability scores and the use of devices: two distinct aspects of physical function in rheumatoid arthritis.

Authors:  A van der Heide; J W Jacobs; G A van Albada-Kuipers; F W Kraaimaat; R Geenen; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

3.  Early rheumatoid arthritis--onset, course, and outcome over 2 years.

Authors:  K B Eberhardt; L C Rydgren; H Pettersson; F A Wollheim
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.